Group B Streptococcus engages an inhibitory Siglec through sialic acid mimicry to blunt innate immune and inflammatory responses in vivo.
Group B Streptococcus (GBS) is a common agent of bacterial sepsis and meningitis in newborns. The GBS surface capsule contains sialic acids (Sia) that engage Sia-binding immunoglobulin-like lectins (Siglecs) on leukocytes. Here we use mice lacking Siglec-E, an inhibitory Siglec of myelomonocytic cel...
Guardado en:
Autores principales: | Yung-Chi Chang, Joshua Olson, Federico C Beasley, Christine Tung, Jiquan Zhang, Paul R Crocker, Ajit Varki, Victor Nizet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e9941a52faf34e3b9368655281ec7f1f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Ernesto Rodriguez, et al.
Publicado: (2021) -
Viral enhancer mimicry of host innate-immune promoters.
por: Kai A Kropp, et al.
Publicado: (2014) -
Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes.
por: Stefania Varchetta, et al.
Publicado: (2012) -
Leukocyte Inflammatory Responses Provoked by Pneumococcal Sialidase
por: Yung-Chi Chang, et al.
Publicado: (2012) -
Distribution of O-Acetylated Sialic Acids among Target Host Tissues for Influenza Virus
por: Brian R. Wasik, et al.
Publicado: (2017)